Certified by Founder Lodge
Bluebird Ventures
United States - Palo Alto, CA
INVESTOR
1 Disclosed Funding Rounds $58,750,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Jeffrey Bird MD PhD, Managing Director, has been an early stage venture investor for 20 years and has been a board member of numerous public companies including Forty Seven, Portola, and Hori
| Company | Date | Round | Raised |
|---|---|---|---|
 Foresight Diagnostics Inc. |
April, 28 ,2023 | Series B | $58,750,000 |
 Procyrion, Inc. |
February, 06 ,2024 | Series E | $57,700,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
